Intrathecal Catheter Granuloma Associated with Continuous Sufentanil Infusion

Anita Gupta, Ty Martindale, Paul Christo

Research output: Contribution to journalArticle

Abstract

Intrathecal sufentanil is a minimally utilized opioid for patients with intractable pain refractory to traditional intrathecal medications. We present an 86-year-old female with a history of multiple spine surgeries who eventually progressed to having chronic, intractable, and diffuse low back pain. After failing medical management, she underwent a successful intrathecal trial of opioid therapy and was subsequently treated with an implantable drug delivery system (IDDS) or intrathecal pump. We describe the first reported case of formation of a catheter tip granuloma associated with intrathecal infusion of sufentanil.Due to increasing opioid requirements and gradually escalating pain, a computed tomography myelogram was performed to explore neuraxial etiologies of her symptoms. This investigation revealed the presence of a catheter tip-associated inflammatory mass (granuloma). All patients receiving intrathecal medications, including sufentanil, must be considered for the possibility of catheter-associated granuloma, particularly with symptoms of altered neurological function and/or increasing medication requirements associated with worsening pain. Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)847-852
Number of pages6
JournalPain Medicine
Volume11
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Sufentanil
Granuloma
Opioid Analgesics
Catheters
Implantable Infusion Pumps
Pain
Intractable Pain
Low Back Pain
Spine
Tomography
Therapeutics

Keywords

  • Chronic Pain
  • FBSS (Failed Back Surgery Syndrome)
  • Interventional

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this

Intrathecal Catheter Granuloma Associated with Continuous Sufentanil Infusion. / Gupta, Anita; Martindale, Ty; Christo, Paul.

In: Pain Medicine, Vol. 11, No. 6, 06.2010, p. 847-852.

Research output: Contribution to journalArticle

Gupta, Anita ; Martindale, Ty ; Christo, Paul. / Intrathecal Catheter Granuloma Associated with Continuous Sufentanil Infusion. In: Pain Medicine. 2010 ; Vol. 11, No. 6. pp. 847-852.
@article{464fc107082d47b48e8cd7ce65023188,
title = "Intrathecal Catheter Granuloma Associated with Continuous Sufentanil Infusion",
abstract = "Intrathecal sufentanil is a minimally utilized opioid for patients with intractable pain refractory to traditional intrathecal medications. We present an 86-year-old female with a history of multiple spine surgeries who eventually progressed to having chronic, intractable, and diffuse low back pain. After failing medical management, she underwent a successful intrathecal trial of opioid therapy and was subsequently treated with an implantable drug delivery system (IDDS) or intrathecal pump. We describe the first reported case of formation of a catheter tip granuloma associated with intrathecal infusion of sufentanil.Due to increasing opioid requirements and gradually escalating pain, a computed tomography myelogram was performed to explore neuraxial etiologies of her symptoms. This investigation revealed the presence of a catheter tip-associated inflammatory mass (granuloma). All patients receiving intrathecal medications, including sufentanil, must be considered for the possibility of catheter-associated granuloma, particularly with symptoms of altered neurological function and/or increasing medication requirements associated with worsening pain. Wiley Periodicals, Inc.",
keywords = "Chronic Pain, FBSS (Failed Back Surgery Syndrome), Interventional",
author = "Anita Gupta and Ty Martindale and Paul Christo",
year = "2010",
month = "6",
doi = "10.1111/j.1526-4637.2010.00860.x",
language = "English (US)",
volume = "11",
pages = "847--852",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Intrathecal Catheter Granuloma Associated with Continuous Sufentanil Infusion

AU - Gupta, Anita

AU - Martindale, Ty

AU - Christo, Paul

PY - 2010/6

Y1 - 2010/6

N2 - Intrathecal sufentanil is a minimally utilized opioid for patients with intractable pain refractory to traditional intrathecal medications. We present an 86-year-old female with a history of multiple spine surgeries who eventually progressed to having chronic, intractable, and diffuse low back pain. After failing medical management, she underwent a successful intrathecal trial of opioid therapy and was subsequently treated with an implantable drug delivery system (IDDS) or intrathecal pump. We describe the first reported case of formation of a catheter tip granuloma associated with intrathecal infusion of sufentanil.Due to increasing opioid requirements and gradually escalating pain, a computed tomography myelogram was performed to explore neuraxial etiologies of her symptoms. This investigation revealed the presence of a catheter tip-associated inflammatory mass (granuloma). All patients receiving intrathecal medications, including sufentanil, must be considered for the possibility of catheter-associated granuloma, particularly with symptoms of altered neurological function and/or increasing medication requirements associated with worsening pain. Wiley Periodicals, Inc.

AB - Intrathecal sufentanil is a minimally utilized opioid for patients with intractable pain refractory to traditional intrathecal medications. We present an 86-year-old female with a history of multiple spine surgeries who eventually progressed to having chronic, intractable, and diffuse low back pain. After failing medical management, she underwent a successful intrathecal trial of opioid therapy and was subsequently treated with an implantable drug delivery system (IDDS) or intrathecal pump. We describe the first reported case of formation of a catheter tip granuloma associated with intrathecal infusion of sufentanil.Due to increasing opioid requirements and gradually escalating pain, a computed tomography myelogram was performed to explore neuraxial etiologies of her symptoms. This investigation revealed the presence of a catheter tip-associated inflammatory mass (granuloma). All patients receiving intrathecal medications, including sufentanil, must be considered for the possibility of catheter-associated granuloma, particularly with symptoms of altered neurological function and/or increasing medication requirements associated with worsening pain. Wiley Periodicals, Inc.

KW - Chronic Pain

KW - FBSS (Failed Back Surgery Syndrome)

KW - Interventional

UR - http://www.scopus.com/inward/record.url?scp=77954440429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954440429&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4637.2010.00860.x

DO - 10.1111/j.1526-4637.2010.00860.x

M3 - Article

VL - 11

SP - 847

EP - 852

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 6

ER -